Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Bioorganic & Medicinal Chemistry|February 26, 2004
Synthesis and biological evaluation of novel macrocyclic bis-7-azaindolylmaleimides as potent and highly selective glycogen synthase kinase-3 beta (GSK-3 beta) inhibitorsLan Shen, Catherine Prouty, Bruce R Conway, et al.Clinical and Experimental Pharmacology & Physiology|April 20, 2006
Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonistJoseph W Gunnet, Jay M Matthews, Bruce E Maryanoff, et al.European Journal of Pharmacology|July 5, 2008
Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonistJoseph W Gunnet, Pamela Wines, Min Xiang, et al.Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Synthesis and biological evaluation of novel indoloazepine derivatives as non-peptide vasopressin V2 receptor antagonistsJay M Matthews, Michael N Greco, Leonard R Hecker, et al.Journal of Cardiovascular Pharmacology|January 7, 2010
Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibitionMargery A Connelly, Tom J Parry, Edward C Giardino, et al.Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3Han-Cheng Zhang, Kimberly B White, Hong Ye, et al.Bioorganic & Medicinal Chemistry Letters|October 19, 2007
Next-generation spirobenzazepines: identification of RWJ-676070 as a balanced vasopressin V1a/V2 receptor antagonist for human clinical studiesMin Amy Xiang, Philip J Rybczynski, Mona Patel, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2004
3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3Han-Cheng Zhang, Hong Ye, Bruce R Conway, et al.Pageof 5